| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Wounds and Injuries | 16 | 2025 | 392 | 6.150 |
Why?
|
| Trauma Centers | 19 | 2026 | 206 | 5.180 |
Why?
|
| Resuscitation | 18 | 2025 | 276 | 4.000 |
Why?
|
| Patient Care Team | 10 | 2025 | 559 | 3.740 |
Why?
|
| Video Recording | 11 | 2025 | 208 | 3.050 |
Why?
|
| Clinical Competence | 12 | 2025 | 1063 | 2.480 |
Why?
|
| Wounds, Nonpenetrating | 5 | 2026 | 215 | 2.320 |
Why?
|
| Hypotension | 3 | 2025 | 183 | 2.210 |
Why?
|
| Thoracotomy | 5 | 2023 | 107 | 2.090 |
Why?
|
| Wounds, Penetrating | 4 | 2026 | 137 | 2.000 |
Why?
|
| Abdominal Injuries | 5 | 2026 | 119 | 2.000 |
Why?
|
| Injury Severity Score | 11 | 2026 | 233 | 2.000 |
Why?
|
| Internship and Residency | 7 | 2025 | 1220 | 1.830 |
Why?
|
| Emergency Medical Services | 4 | 2023 | 387 | 1.780 |
Why?
|
| Patient Handoff | 3 | 2024 | 23 | 1.680 |
Why?
|
| Emergency Service, Hospital | 8 | 2023 | 1219 | 1.650 |
Why?
|
| Cholecystectomy, Laparoscopic | 5 | 2024 | 39 | 1.500 |
Why?
|
| Thoracic Injuries | 3 | 2023 | 84 | 1.450 |
Why?
|
| Hemorrhage | 5 | 2025 | 490 | 1.430 |
Why?
|
| Surgeons | 3 | 2025 | 288 | 1.250 |
Why?
|
| Colon | 4 | 2026 | 363 | 1.120 |
Why?
|
| Cholecystitis | 4 | 2024 | 20 | 1.110 |
Why?
|
| Leadership | 4 | 2025 | 244 | 1.110 |
Why?
|
| Colectomy | 2 | 2025 | 89 | 1.060 |
Why?
|
| Cholecystitis, Acute | 3 | 2025 | 15 | 1.040 |
Why?
|
| Heart Arrest | 2 | 2024 | 380 | 1.030 |
Why?
|
| Catheterization, Central Venous | 2 | 2026 | 136 | 1.020 |
Why?
|
| Balloon Occlusion | 3 | 2021 | 48 | 0.980 |
Why?
|
| Abdominal Abscess | 2 | 2023 | 23 | 0.970 |
Why?
|
| Rib Fractures | 2 | 2023 | 28 | 0.970 |
Why?
|
| Central Venous Catheters | 2 | 2025 | 50 | 0.950 |
Why?
|
| Adult | 46 | 2026 | 31145 | 0.940 |
Why?
|
| Humans | 139 | 2026 | 130481 | 0.910 |
Why?
|
| Tranexamic Acid | 1 | 2025 | 31 | 0.900 |
Why?
|
| Nerve Block | 2 | 2023 | 68 | 0.890 |
Why?
|
| Antifibrinolytic Agents | 1 | 2025 | 47 | 0.890 |
Why?
|
| Middle Aged | 46 | 2026 | 28393 | 0.860 |
Why?
|
| Simulation Training | 3 | 2022 | 170 | 0.840 |
Why?
|
| Colonic Diseases | 2 | 2023 | 36 | 0.820 |
Why?
|
| Shock, Hemorrhagic | 2 | 2021 | 51 | 0.820 |
Why?
|
| Resilience, Psychological | 1 | 2025 | 80 | 0.820 |
Why?
|
| Fractures, Bone | 1 | 2026 | 215 | 0.800 |
Why?
|
| Retrospective Studies | 34 | 2026 | 17529 | 0.780 |
Why?
|
| Operating Rooms | 2 | 2022 | 74 | 0.780 |
Why?
|
| Spinal Fractures | 1 | 2023 | 49 | 0.780 |
Why?
|
| Fasciotomy | 1 | 2023 | 25 | 0.770 |
Why?
|
| Intubation, Intratracheal | 3 | 2020 | 287 | 0.760 |
Why?
|
| Male | 89 | 2026 | 64495 | 0.750 |
Why?
|
| Time Perception | 1 | 2022 | 9 | 0.730 |
Why?
|
| Leg | 1 | 2023 | 119 | 0.730 |
Why?
|
| Patient Discharge | 1 | 2026 | 513 | 0.720 |
Why?
|
| Needs Assessment | 2 | 2023 | 174 | 0.700 |
Why?
|
| Female | 79 | 2026 | 70399 | 0.690 |
Why?
|
| Mentoring | 1 | 2023 | 84 | 0.690 |
Why?
|
| Triage | 1 | 2022 | 143 | 0.690 |
Why?
|
| Appendectomy | 2 | 2020 | 88 | 0.680 |
Why?
|
| Prospective Studies | 20 | 2024 | 6451 | 0.660 |
Why?
|
| Endovascular Procedures | 4 | 2021 | 778 | 0.640 |
Why?
|
| Surgical Wound | 1 | 2020 | 21 | 0.640 |
Why?
|
| General Surgery | 1 | 2023 | 225 | 0.640 |
Why?
|
| Appendicitis | 2 | 2020 | 132 | 0.640 |
Why?
|
| Education, Medical, Graduate | 1 | 2025 | 552 | 0.630 |
Why?
|
| Cholecystectomy | 9 | 2025 | 57 | 0.600 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2023 | 325 | 0.570 |
Why?
|
| Students, Medical | 1 | 2023 | 351 | 0.550 |
Why?
|
| Hospitals, Urban | 1 | 2018 | 97 | 0.550 |
Why?
|
| Clinical Decision-Making | 1 | 2019 | 311 | 0.510 |
Why?
|
| Physicians | 1 | 2023 | 635 | 0.490 |
Why?
|
| Communication | 5 | 2025 | 539 | 0.480 |
Why?
|
| Infusions, Intraosseous | 3 | 2026 | 23 | 0.460 |
Why?
|
| Time-to-Treatment | 3 | 2024 | 210 | 0.440 |
Why?
|
| Colostomy | 2 | 2025 | 29 | 0.430 |
Why?
|
| Laparoscopy | 2 | 2018 | 536 | 0.430 |
Why?
|
| Survival Rate | 3 | 2018 | 2112 | 0.420 |
Why?
|
| Young Adult | 9 | 2025 | 9997 | 0.420 |
Why?
|
| Surgical Wound Infection | 2 | 2026 | 266 | 0.390 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2019 | 775 | 0.390 |
Why?
|
| Length of Stay | 6 | 2025 | 1398 | 0.370 |
Why?
|
| Traumatology | 2 | 2024 | 25 | 0.360 |
Why?
|
| Treatment Outcome | 12 | 2025 | 12850 | 0.350 |
Why?
|
| Anastomosis, Surgical | 3 | 2026 | 176 | 0.320 |
Why?
|
| Pain Management | 2 | 2023 | 204 | 0.310 |
Why?
|
| Cerebral Infarction | 4 | 1994 | 47 | 0.310 |
Why?
|
| Pennsylvania | 2 | 2019 | 60 | 0.290 |
Why?
|
| Wounds, Gunshot | 2 | 2022 | 147 | 0.290 |
Why?
|
| Aorta | 5 | 2021 | 521 | 0.280 |
Why?
|
| Pancreatic Neoplasms | 6 | 2015 | 734 | 0.270 |
Why?
|
| Venous Thromboembolism | 2 | 2021 | 192 | 0.270 |
Why?
|
| Curriculum | 2 | 2023 | 790 | 0.260 |
Why?
|
| Cerebrovascular Disorders | 3 | 1997 | 112 | 0.260 |
Why?
|
| Gallbladder | 2 | 2024 | 19 | 0.260 |
Why?
|
| Carcinoma, Pancreatic Ductal | 3 | 2015 | 191 | 0.260 |
Why?
|
| Biliary Tract Diseases | 3 | 2025 | 32 | 0.260 |
Why?
|
| Cross-Sectional Studies | 4 | 2025 | 3798 | 0.260 |
Why?
|
| Postoperative Complications | 6 | 2025 | 3123 | 0.240 |
Why?
|
| Registries | 6 | 2020 | 1617 | 0.240 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2026 | 57 | 0.240 |
Why?
|
| United States | 7 | 2025 | 11880 | 0.240 |
Why?
|
| Ultrasonography, Doppler | 1 | 2026 | 185 | 0.220 |
Why?
|
| Quality Improvement | 4 | 2024 | 709 | 0.220 |
Why?
|
| Observational Studies as Topic | 1 | 2025 | 102 | 0.220 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2025 | 85 | 0.210 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 7 | 1999 | 79 | 0.210 |
Why?
|
| Aged | 23 | 2026 | 20883 | 0.210 |
Why?
|
| Workload | 1 | 2025 | 149 | 0.210 |
Why?
|
| Multicenter Studies as Topic | 1 | 2025 | 299 | 0.210 |
Why?
|
| Bile Ducts | 1 | 2024 | 52 | 0.210 |
Why?
|
| Infusions, Intravenous | 2 | 2023 | 535 | 0.210 |
Why?
|
| Bays | 1 | 2023 | 7 | 0.200 |
Why?
|
| Practice Guidelines as Topic | 3 | 2025 | 1289 | 0.200 |
Why?
|
| Morphine | 1 | 2023 | 80 | 0.200 |
Why?
|
| Duodenum | 1 | 2024 | 112 | 0.200 |
Why?
|
| Thoracostomy | 1 | 2023 | 26 | 0.190 |
Why?
|
| Chest Tubes | 1 | 2023 | 38 | 0.190 |
Why?
|
| Injections, Intravenous | 1 | 2023 | 236 | 0.190 |
Why?
|
| Patient Acuity | 1 | 2023 | 66 | 0.190 |
Why?
|
| Ischemic Attack, Transient | 2 | 1994 | 60 | 0.190 |
Why?
|
| Predictive Value of Tests | 2 | 2026 | 2294 | 0.190 |
Why?
|
| Orthopedics | 1 | 2023 | 76 | 0.190 |
Why?
|
| Safety-net Providers | 2 | 2025 | 89 | 0.180 |
Why?
|
| Postoperative Care | 1 | 2024 | 294 | 0.180 |
Why?
|
| Operative Time | 1 | 2023 | 199 | 0.180 |
Why?
|
| Machine Learning | 2 | 2023 | 381 | 0.180 |
Why?
|
| Perception | 1 | 2023 | 229 | 0.170 |
Why?
|
| Enteral Nutrition | 1 | 2024 | 285 | 0.170 |
Why?
|
| Tissue and Organ Procurement | 1 | 2024 | 254 | 0.170 |
Why?
|
| Mentors | 1 | 2023 | 168 | 0.170 |
Why?
|
| Analgesics, Opioid | 2 | 2023 | 483 | 0.170 |
Why?
|
| Pain | 1 | 2023 | 429 | 0.160 |
Why?
|
| Severity of Illness Index | 3 | 2025 | 3031 | 0.160 |
Why?
|
| Laparotomy | 1 | 2021 | 138 | 0.160 |
Why?
|
| Time Factors | 5 | 2025 | 6199 | 0.160 |
Why?
|
| France | 8 | 1999 | 90 | 0.160 |
Why?
|
| Catheters | 1 | 2020 | 83 | 0.150 |
Why?
|
| Educational Measurement | 1 | 2022 | 316 | 0.150 |
Why?
|
| Patient Safety | 1 | 2023 | 444 | 0.140 |
Why?
|
| Torso | 1 | 2018 | 13 | 0.140 |
Why?
|
| Embolization, Therapeutic | 1 | 2021 | 225 | 0.140 |
Why?
|
| Population Surveillance | 5 | 2011 | 393 | 0.140 |
Why?
|
| Artificial Intelligence | 1 | 2023 | 352 | 0.140 |
Why?
|
| Wounds, Stab | 1 | 2018 | 35 | 0.140 |
Why?
|
| Catheterization | 1 | 2020 | 225 | 0.140 |
Why?
|
| Hemostatic Techniques | 1 | 2018 | 26 | 0.140 |
Why?
|
| Specialties, Surgical | 1 | 2020 | 90 | 0.140 |
Why?
|
| Health Care Surveys | 1 | 2019 | 277 | 0.140 |
Why?
|
| Aged, 80 and over | 14 | 2020 | 6793 | 0.140 |
Why?
|
| Cholelithiasis | 4 | 1999 | 16 | 0.140 |
Why?
|
| Texas | 2 | 2025 | 3643 | 0.140 |
Why?
|
| Pancreas | 3 | 2013 | 219 | 0.140 |
Why?
|
| Vascular Access Devices | 1 | 2018 | 34 | 0.140 |
Why?
|
| Blood Pressure | 1 | 2023 | 1344 | 0.130 |
Why?
|
| Benchmarking | 1 | 2018 | 135 | 0.130 |
Why?
|
| Vascular System Injuries | 1 | 2018 | 57 | 0.130 |
Why?
|
| Health Services Needs and Demand | 1 | 2018 | 170 | 0.130 |
Why?
|
| Pancreatectomy | 4 | 2013 | 147 | 0.130 |
Why?
|
| Hospitalization | 2 | 2023 | 1930 | 0.120 |
Why?
|
| Surgical Procedures, Operative | 1 | 2019 | 225 | 0.120 |
Why?
|
| Logistic Models | 2 | 2018 | 1801 | 0.120 |
Why?
|
| Critical Care | 1 | 2022 | 685 | 0.120 |
Why?
|
| Algorithms | 1 | 2023 | 1663 | 0.120 |
Why?
|
| Risk Assessment | 1 | 2026 | 3675 | 0.120 |
Why?
|
| Cerebral Hemorrhage | 3 | 1997 | 159 | 0.120 |
Why?
|
| Intensive Care Units | 1 | 2020 | 526 | 0.120 |
Why?
|
| Anticoagulants | 1 | 2021 | 602 | 0.120 |
Why?
|
| Cohort Studies | 2 | 2023 | 5049 | 0.120 |
Why?
|
| I-kappa B Proteins | 1 | 2015 | 36 | 0.110 |
Why?
|
| Pandemics | 1 | 2023 | 1161 | 0.110 |
Why?
|
| Drainage | 1 | 1997 | 247 | 0.110 |
Why?
|
| Deoxycytidine | 1 | 2015 | 81 | 0.110 |
Why?
|
| Ferredoxin-NADP Reductase | 2 | 2008 | 8 | 0.100 |
Why?
|
| Liver | 2 | 2021 | 1788 | 0.100 |
Why?
|
| Pancreatitis | 5 | 2000 | 138 | 0.100 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2015 | 186 | 0.100 |
Why?
|
| Pancreatic Cyst | 1 | 2013 | 28 | 0.100 |
Why?
|
| Aorta, Thoracic | 1 | 2018 | 528 | 0.100 |
Why?
|
| Hospital Mortality | 1 | 2018 | 1059 | 0.100 |
Why?
|
| Surveys and Questionnaires | 1 | 2023 | 4029 | 0.100 |
Why?
|
| Acute Disease | 7 | 2025 | 1148 | 0.090 |
Why?
|
| Liver Transplantation | 1 | 2021 | 1127 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2013 | 331 | 0.090 |
Why?
|
| Precancerous Conditions | 1 | 2013 | 280 | 0.080 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2015 | 816 | 0.080 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2018 | 747 | 0.080 |
Why?
|
| Pancreatitis, Alcoholic | 2 | 1999 | 4 | 0.080 |
Why?
|
| Weight-Bearing | 1 | 2009 | 44 | 0.080 |
Why?
|
| Hip Joint | 1 | 2009 | 47 | 0.070 |
Why?
|
| Duodenoscopy | 2 | 2007 | 16 | 0.070 |
Why?
|
| Robotics | 1 | 2010 | 102 | 0.070 |
Why?
|
| Muscle Contraction | 1 | 2009 | 146 | 0.070 |
Why?
|
| Reproducibility of Results | 3 | 2023 | 2900 | 0.070 |
Why?
|
| Duodenal Obstruction | 2 | 2007 | 13 | 0.070 |
Why?
|
| Sphincterotomy, Endoscopic | 3 | 1999 | 11 | 0.070 |
Why?
|
| Gait | 1 | 2009 | 141 | 0.070 |
Why?
|
| Data Collection | 2 | 2022 | 370 | 0.070 |
Why?
|
| Walking | 1 | 2009 | 227 | 0.060 |
Why?
|
| Prosthesis Implantation | 1 | 2007 | 151 | 0.060 |
Why?
|
| Single-Blind Method | 1 | 2026 | 236 | 0.060 |
Why?
|
| Risk Factors | 7 | 2020 | 10949 | 0.060 |
Why?
|
| Hypertension, Renal | 3 | 1981 | 30 | 0.060 |
Why?
|
| Atrial Fibrillation | 1 | 1993 | 737 | 0.060 |
Why?
|
| Health Insurance Portability and Accountability Act | 1 | 2024 | 21 | 0.050 |
Why?
|
| Models, Biological | 1 | 2009 | 1384 | 0.050 |
Why?
|
| Brain Death | 1 | 2024 | 73 | 0.050 |
Why?
|
| Confidentiality | 1 | 2024 | 107 | 0.050 |
Why?
|
| Palliative Care | 1 | 2007 | 445 | 0.050 |
Why?
|
| Pancreatic Diseases | 2 | 1994 | 41 | 0.050 |
Why?
|
| Intraoperative Complications | 1 | 2024 | 154 | 0.050 |
Why?
|
| Prognosis | 7 | 2011 | 4863 | 0.050 |
Why?
|
| Muscle, Skeletal | 1 | 2009 | 1000 | 0.050 |
Why?
|
| Patient Transfer | 1 | 2024 | 109 | 0.050 |
Why?
|
| Glomerulonephritis | 2 | 1976 | 75 | 0.050 |
Why?
|
| Parenteral Nutrition | 1 | 2024 | 218 | 0.050 |
Why?
|
| Informed Consent | 1 | 2024 | 350 | 0.040 |
Why?
|
| Stents | 1 | 2007 | 781 | 0.040 |
Why?
|
| Poverty | 1 | 2025 | 450 | 0.040 |
Why?
|
| Hypertension, Malignant | 1 | 1981 | 7 | 0.040 |
Why?
|
| Hepatic Artery | 1 | 2021 | 45 | 0.040 |
Why?
|
| Radiology, Interventional | 1 | 2021 | 30 | 0.040 |
Why?
|
| Patient Readmission | 1 | 2025 | 433 | 0.040 |
Why?
|
| Paraspinal Muscles | 1 | 2021 | 8 | 0.040 |
Why?
|
| Tissue Donors | 1 | 2024 | 500 | 0.040 |
Why?
|
| Body Mass Index | 2 | 2025 | 1676 | 0.040 |
Why?
|
| Hemolytic-Uremic Syndrome | 1 | 1981 | 33 | 0.040 |
Why?
|
| Sex Factors | 4 | 1999 | 1339 | 0.040 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2001 | 43 | 0.040 |
Why?
|
| Trauma Severity Indices | 1 | 2021 | 87 | 0.040 |
Why?
|
| Incidence | 4 | 1999 | 3317 | 0.040 |
Why?
|
| American Nurses' Association | 1 | 1980 | 2 | 0.040 |
Why?
|
| Teratogens | 1 | 2001 | 67 | 0.040 |
Why?
|
| Codeine | 1 | 2000 | 23 | 0.040 |
Why?
|
| Bicarbonates | 2 | 1970 | 98 | 0.040 |
Why?
|
| Nursing | 1 | 1980 | 9 | 0.040 |
Why?
|
| Adenocarcinoma | 1 | 2007 | 965 | 0.040 |
Why?
|
| Chlorides | 2 | 1970 | 97 | 0.040 |
Why?
|
| ROC Curve | 1 | 2022 | 611 | 0.040 |
Why?
|
| Anesthetics, Local | 1 | 2021 | 85 | 0.040 |
Why?
|
| Health Plan Implementation | 1 | 2020 | 39 | 0.040 |
Why?
|
| Glasgow Coma Scale | 1 | 2020 | 204 | 0.040 |
Why?
|
| Bile | 1 | 1999 | 44 | 0.040 |
Why?
|
| Brain Injuries | 1 | 2024 | 703 | 0.040 |
Why?
|
| Ethanol | 1 | 2001 | 167 | 0.040 |
Why?
|
| Sensitivity and Specificity | 3 | 2013 | 2089 | 0.040 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 1999 | 38 | 0.040 |
Why?
|
| Organizational Innovation | 1 | 2019 | 41 | 0.040 |
Why?
|
| Endosonography | 1 | 1999 | 75 | 0.040 |
Why?
|
| Forecasting | 1 | 1980 | 350 | 0.040 |
Why?
|
| Child | 34 | 1991 | 26119 | 0.040 |
Why?
|
| Adolescent | 20 | 2020 | 20733 | 0.040 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2001 | 227 | 0.040 |
Why?
|
| 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 1 | 1998 | 19 | 0.030 |
Why?
|
| Flavoproteins | 1 | 1998 | 21 | 0.030 |
Why?
|
| Hematuria | 1 | 1978 | 48 | 0.030 |
Why?
|
| Kidney Diseases | 5 | 1978 | 471 | 0.030 |
Why?
|
| Multivariate Analysis | 2 | 2018 | 1376 | 0.030 |
Why?
|
| Homocystinuria | 1 | 1998 | 26 | 0.030 |
Why?
|
| Patient Care Planning | 1 | 2019 | 124 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2020 | 443 | 0.030 |
Why?
|
| Ophthalmoplegia | 3 | 1980 | 52 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 1998 | 108 | 0.030 |
Why?
|
| Bile Acids and Salts | 1 | 1999 | 260 | 0.030 |
Why?
|
| Pancreatic Pseudocyst | 2 | 2013 | 14 | 0.030 |
Why?
|
| Mycoplasma Infections | 1 | 1976 | 9 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2018 | 565 | 0.030 |
Why?
|
| Kidney | 3 | 1981 | 1277 | 0.030 |
Why?
|
| Retinitis Pigmentosa | 2 | 1979 | 76 | 0.030 |
Why?
|
| Age Distribution | 1 | 1997 | 422 | 0.030 |
Why?
|
| Pneumoperitoneum | 1 | 1995 | 9 | 0.030 |
Why?
|
| Heart Defects, Congenital | 5 | 1988 | 1874 | 0.030 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2015 | 32 | 0.030 |
Why?
|
| Parotitis | 1 | 1975 | 5 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2013 | 1594 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2018 | 1210 | 0.030 |
Why?
|
| Arteriosclerosis | 1 | 1994 | 110 | 0.030 |
Why?
|
| Random Allocation | 1 | 2015 | 414 | 0.030 |
Why?
|
| Arthrogryposis | 1 | 1974 | 37 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 3 | 1994 | 2062 | 0.030 |
Why?
|
| Abnormalities, Multiple | 5 | 1988 | 964 | 0.030 |
Why?
|
| Pancreatic Ducts | 1 | 1994 | 19 | 0.030 |
Why?
|
| Gallstones | 1 | 1993 | 18 | 0.030 |
Why?
|
| Myocardial Ischemia | 1 | 1997 | 309 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2013 | 57 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2015 | 699 | 0.030 |
Why?
|
| Hypercalcemia | 2 | 1970 | 41 | 0.030 |
Why?
|
| Arrhythmias, Cardiac | 2 | 1997 | 485 | 0.030 |
Why?
|
| Hospitals | 1 | 1997 | 437 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2015 | 726 | 0.030 |
Why?
|
| Obesity | 2 | 2025 | 2381 | 0.030 |
Why?
|
| Alkalosis | 2 | 1970 | 23 | 0.030 |
Why?
|
| Sjogren's Syndrome | 1 | 1975 | 108 | 0.020 |
Why?
|
| Urate Oxidase | 1 | 1973 | 16 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2015 | 441 | 0.020 |
Why?
|
| Peritoneal Dialysis | 2 | 1972 | 132 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 1970 | 410 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2018 | 1223 | 0.020 |
Why?
|
| Neuroendocrine Tumors | 1 | 1994 | 68 | 0.020 |
Why?
|
| Age Factors | 2 | 1989 | 2828 | 0.020 |
Why?
|
| Uric Acid | 1 | 1973 | 110 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2015 | 999 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 785 | 0.020 |
Why?
|
| Hypocalcemia | 1 | 1972 | 36 | 0.020 |
Why?
|
| Prevalence | 2 | 1999 | 2687 | 0.020 |
Why?
|
| Brain | 2 | 2001 | 3180 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 1993 | 226 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2013 | 1016 | 0.020 |
Why?
|
| Metabolic Diseases | 1 | 1973 | 140 | 0.020 |
Why?
|
| Blepharoptosis | 1 | 1972 | 67 | 0.020 |
Why?
|
| Syndrome | 8 | 1995 | 1159 | 0.020 |
Why?
|
| Chromosomes, Human, 13-15 | 1 | 1971 | 2 | 0.020 |
Why?
|
| Carbonates | 1 | 1970 | 6 | 0.020 |
Why?
|
| Acid-Base Equilibrium | 1 | 1970 | 60 | 0.020 |
Why?
|
| Diarrhea, Infantile | 1 | 1970 | 31 | 0.020 |
Why?
|
| Streptococcal Infections | 2 | 1976 | 254 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 2008 | 2398 | 0.020 |
Why?
|
| Muscular Diseases | 1 | 1971 | 124 | 0.020 |
Why?
|
| Risk | 1 | 2011 | 722 | 0.020 |
Why?
|
| Base Sequence | 2 | 2008 | 2737 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 2013 | 1878 | 0.020 |
Why?
|
| Brain Diseases | 1 | 1972 | 298 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2008 | 3471 | 0.020 |
Why?
|
| Child, Preschool | 16 | 1983 | 14964 | 0.020 |
Why?
|
| Microscopy, Electron | 4 | 2001 | 308 | 0.020 |
Why?
|
| Diarrhea | 1 | 1970 | 316 | 0.020 |
Why?
|
| Polycystic Kidney Diseases | 1 | 1988 | 31 | 0.020 |
Why?
|
| Myocardium | 2 | 1986 | 857 | 0.020 |
Why?
|
| Dwarfism | 3 | 1986 | 104 | 0.020 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 1989 | 72 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 1971 | 574 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2015 | 2464 | 0.020 |
Why?
|
| Nasopharyngeal Diseases | 1 | 1967 | 4 | 0.020 |
Why?
|
| Otitis | 1 | 1967 | 11 | 0.020 |
Why?
|
| Stomatitis | 1 | 1967 | 14 | 0.020 |
Why?
|
| Ampulla of Vater | 1 | 2007 | 15 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2010 | 547 | 0.020 |
Why?
|
| Common Bile Duct Neoplasms | 1 | 2007 | 10 | 0.020 |
Why?
|
| Intellectual Disability | 4 | 1981 | 1085 | 0.020 |
Why?
|
| Vitamin B 12 | 1 | 2008 | 58 | 0.020 |
Why?
|
| Skin Diseases, Infectious | 1 | 1967 | 25 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2011 | 416 | 0.020 |
Why?
|
| Urinary Tract | 1 | 1988 | 54 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2015 | 3714 | 0.020 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 1988 | 77 | 0.020 |
Why?
|
| Seasons | 1 | 1989 | 333 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2015 | 1587 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2008 | 250 | 0.020 |
Why?
|
| Face | 3 | 1983 | 189 | 0.020 |
Why?
|
| Pyelonephritis | 1 | 1967 | 27 | 0.020 |
Why?
|
| Duodenal Diseases | 1 | 1987 | 28 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2008 | 267 | 0.020 |
Why?
|
| Kidney Failure, Chronic | 2 | 1973 | 938 | 0.020 |
Why?
|
| Renal Dialysis | 2 | 1971 | 948 | 0.020 |
Why?
|
| Constriction, Pathologic | 1 | 2007 | 223 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2008 | 583 | 0.020 |
Why?
|
| Thymus Hormones | 1 | 1986 | 2 | 0.020 |
Why?
|
| Cockayne Syndrome | 1 | 1986 | 6 | 0.020 |
Why?
|
| Immunoglobulin A | 3 | 1976 | 205 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2009 | 672 | 0.020 |
Why?
|
| Heart Block | 2 | 1979 | 37 | 0.010 |
Why?
|
| Anemia, Hemolytic | 1 | 1966 | 31 | 0.010 |
Why?
|
| Phosphorus | 2 | 1979 | 60 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 2008 | 310 | 0.010 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 1 | 1966 | 52 | 0.010 |
Why?
|
| Bile Duct Diseases | 1 | 1985 | 16 | 0.010 |
Why?
|
| Disease Progression | 1 | 2011 | 2193 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 2 | 1976 | 413 | 0.010 |
Why?
|
| Uremia | 1 | 1964 | 33 | 0.010 |
Why?
|
| Bone Diseases | 2 | 1975 | 48 | 0.010 |
Why?
|
| Biomarkers | 1 | 2013 | 3384 | 0.010 |
Why?
|
| Urologic Diseases | 1 | 1964 | 42 | 0.010 |
Why?
|
| Kyphosis | 1 | 1983 | 22 | 0.010 |
Why?
|
| Achondroplasia | 1 | 1983 | 24 | 0.010 |
Why?
|
| Urology | 1 | 1964 | 80 | 0.010 |
Why?
|
| Animals | 6 | 2015 | 33849 | 0.010 |
Why?
|
| Myelin Sheath | 1 | 1983 | 125 | 0.010 |
Why?
|
| Mice | 2 | 2015 | 18221 | 0.010 |
Why?
|
| Electromyography | 3 | 1972 | 135 | 0.010 |
Why?
|
| Chronic Disease | 2 | 1999 | 1240 | 0.010 |
Why?
|
| Mitochondria | 1 | 2008 | 777 | 0.010 |
Why?
|
| Infant | 10 | 1987 | 13254 | 0.010 |
Why?
|
| Spine | 1 | 1983 | 151 | 0.010 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1983 | 132 | 0.010 |
Why?
|
| Muscular Atrophy | 2 | 1974 | 83 | 0.010 |
Why?
|
| Scoliosis | 1 | 1983 | 152 | 0.010 |
Why?
|
| Nevus | 1 | 1981 | 34 | 0.010 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2001 | 25 | 0.010 |
Why?
|
| Calcium | 2 | 1979 | 1022 | 0.010 |
Why?
|
| Sphincter of Oddi | 1 | 2000 | 1 | 0.010 |
Why?
|
| Cardiomyopathies | 1 | 1986 | 517 | 0.010 |
Why?
|
| Perfusion | 3 | 1970 | 211 | 0.010 |
Why?
|
| Renin | 2 | 1979 | 75 | 0.010 |
Why?
|
| Respiratory Insufficiency | 1 | 1983 | 242 | 0.010 |
Why?
|
| Microcirculation | 1 | 2001 | 104 | 0.010 |
Why?
|
| Brucellosis | 1 | 1980 | 19 | 0.010 |
Why?
|
| Congenital Abnormalities | 1 | 1964 | 322 | 0.010 |
Why?
|
| Ultrasonography | 2 | 1999 | 955 | 0.010 |
Why?
|
| Kidney Function Tests | 2 | 1970 | 136 | 0.010 |
Why?
|
| Cortisone | 1 | 1979 | 10 | 0.010 |
Why?
|
| Lung Diseases | 2 | 1976 | 396 | 0.010 |
Why?
|
| Blood-Brain Barrier | 1 | 2001 | 154 | 0.010 |
Why?
|
| Body Height | 2 | 1971 | 194 | 0.010 |
Why?
|
| Double Outlet Right Ventricle | 1 | 1979 | 19 | 0.010 |
Why?
|
| Nephrotic Syndrome | 1 | 1979 | 53 | 0.010 |
Why?
|
| Acute Kidney Injury | 1 | 1967 | 695 | 0.010 |
Why?
|
| Contraceptives, Oral | 1 | 1999 | 37 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1999 | 148 | 0.010 |
Why?
|
| Hypertension, Renovascular | 1 | 1979 | 28 | 0.010 |
Why?
|
| Cross-Cultural Comparison | 1 | 1999 | 58 | 0.010 |
Why?
|
| Phospholipids | 1 | 1999 | 99 | 0.010 |
Why?
|
| Cholesterol | 2 | 1999 | 538 | 0.010 |
Why?
|
| Absorptiometry, Photon | 1 | 1999 | 197 | 0.010 |
Why?
|
| Growth Disorders | 1 | 1980 | 183 | 0.010 |
Why?
|
| Nephritis | 1 | 1978 | 17 | 0.010 |
Why?
|
| Nephritis, Hereditary | 1 | 1978 | 21 | 0.010 |
Why?
|
| Cleft Lip | 1 | 1981 | 193 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1999 | 319 | 0.010 |
Why?
|
| Cleft Palate | 1 | 1981 | 219 | 0.010 |
Why?
|
| Hybrid Cells | 1 | 1998 | 77 | 0.010 |
Why?
|
| Radiography | 3 | 1995 | 743 | 0.010 |
Why?
|
| Genetic Complementation Test | 1 | 1998 | 89 | 0.010 |
Why?
|
| Secondary Prevention | 1 | 1999 | 217 | 0.010 |
Why?
|
| Heart Conduction System | 1 | 1979 | 162 | 0.010 |
Why?
|
| Wilms Tumor | 1 | 1979 | 117 | 0.010 |
Why?
|
| Pregnancy | 2 | 2001 | 7418 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1998 | 425 | 0.010 |
Why?
|
| Lymphatic Diseases | 1 | 1977 | 26 | 0.010 |
Why?
|
| Antibody Formation | 2 | 1975 | 227 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1998 | 623 | 0.010 |
Why?
|
| Antistreptolysin | 1 | 1976 | 2 | 0.010 |
Why?
|
| Dysgammaglobulinemia | 1 | 1976 | 3 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 1998 | 576 | 0.010 |
Why?
|
| Agranulocytosis | 1 | 1976 | 12 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1998 | 780 | 0.010 |
Why?
|
| Alcohol Drinking | 1 | 1999 | 337 | 0.010 |
Why?
|
| Basement Membrane | 1 | 1976 | 40 | 0.010 |
Why?
|
| Complement C3 | 1 | 1976 | 43 | 0.010 |
Why?
|
| Turner Syndrome | 1 | 1976 | 44 | 0.010 |
Why?
|
| Hematologic Diseases | 1 | 1977 | 82 | 0.010 |
Why?
|
| Hypothyroidism | 2 | 1974 | 76 | 0.010 |
Why?
|
| Reoperation | 1 | 1999 | 818 | 0.010 |
Why?
|
| Respiratory Function Tests | 2 | 1980 | 220 | 0.010 |
Why?
|
| Sialography | 1 | 1975 | 1 | 0.010 |
Why?
|
| Parotid Gland | 1 | 1975 | 17 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 1998 | 1046 | 0.010 |
Why?
|
| Respiratory Tract Infections | 1 | 1978 | 297 | 0.010 |
Why?
|
| Myotonia | 1 | 1975 | 2 | 0.010 |
Why?
|
| Cardiac Catheterization | 1 | 1979 | 623 | 0.010 |
Why?
|
| Karyotyping | 2 | 1976 | 308 | 0.010 |
Why?
|
| Sural Nerve | 2 | 1986 | 46 | 0.010 |
Why?
|
| Lung | 2 | 1980 | 1535 | 0.010 |
Why?
|
| Clubfoot | 1 | 1974 | 20 | 0.010 |
Why?
|
| Joint Diseases | 1 | 1975 | 32 | 0.010 |
Why?
|
| Autoimmune Diseases | 1 | 1977 | 265 | 0.010 |
Why?
|
| Kidney Neoplasms | 1 | 1979 | 420 | 0.010 |
Why?
|
| Muscles | 2 | 1975 | 202 | 0.010 |
Why?
|
| Skin Abnormalities | 1 | 1974 | 34 | 0.010 |
Why?
|
| Chyle | 1 | 1974 | 4 | 0.010 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 1976 | 212 | 0.010 |
Why?
|
| Saliva | 1 | 1975 | 126 | 0.010 |
Why?
|
| Recurrence | 1 | 1978 | 1472 | 0.010 |
Why?
|
| Thyroglobulin | 1 | 1974 | 7 | 0.010 |
Why?
|
| Chylothorax | 1 | 1974 | 27 | 0.010 |
Why?
|
| Water-Electrolyte Balance | 2 | 1972 | 81 | 0.010 |
Why?
|
| Tuberculosis, Miliary | 2 | 1972 | 10 | 0.010 |
Why?
|
| Contraindications | 1 | 1993 | 75 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 1981 | 901 | 0.010 |
Why?
|
| Pituitary Neoplasms | 1 | 1974 | 75 | 0.010 |
Why?
|
| Columbidae | 2 | 1971 | 8 | 0.010 |
Why?
|
| Ascites | 1 | 1974 | 98 | 0.010 |
Why?
|
| Thyroid Hormones | 1 | 1974 | 54 | 0.010 |
Why?
|
| Respiratory Hypersensitivity | 2 | 1971 | 56 | 0.010 |
Why?
|
| Cryptorchidism | 2 | 1988 | 37 | 0.010 |
Why?
|
| Aging | 1 | 2001 | 1243 | 0.010 |
Why?
|
| Adenoma | 1 | 1974 | 143 | 0.010 |
Why?
|
| Diabetic Coma | 1 | 1972 | 2 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 1994 | 356 | 0.010 |
Why?
|
| Cholangitis | 1 | 1992 | 38 | 0.010 |
Why?
|
| Neoplasms | 1 | 2007 | 2966 | 0.010 |
Why?
|
| Metabolism, Inborn Errors | 1 | 1974 | 125 | 0.010 |
Why?
|
| Ataxia Telangiectasia | 1 | 1972 | 13 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 1998 | 1695 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 1975 | 510 | 0.010 |
Why?
|
| Infant, Newborn | 5 | 1987 | 8548 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 1975 | 793 | 0.010 |
Why?
|
| Chronic Kidney Disease-Mineral and Bone Disorder | 1 | 1971 | 14 | 0.010 |
Why?
|
| Isoniazid | 1 | 1972 | 67 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2001 | 4716 | 0.010 |
Why?
|
| Rifampin | 1 | 1972 | 123 | 0.010 |
Why?
|
| Dermatoglyphics | 1 | 1971 | 3 | 0.010 |
Why?
|
| Hypoventilation | 1 | 1971 | 12 | 0.010 |
Why?
|
| Autoradiography | 1 | 1971 | 63 | 0.010 |
Why?
|
| Myofibrils | 1 | 1971 | 24 | 0.010 |
Why?
|
| Bronchial Diseases | 1 | 1971 | 12 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1971 | 73 | 0.010 |
Why?
|
| Gluconates | 1 | 1970 | 3 | 0.010 |
Why?
|
| Acidosis, Renal Tubular | 1 | 1970 | 6 | 0.010 |
Why?
|
| Hypokalemia | 1 | 1970 | 40 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 1970 | 90 | 0.010 |
Why?
|
| Kidney Tubules | 1 | 1970 | 76 | 0.010 |
Why?
|
| Farmer's Lung | 1 | 1970 | 1 | 0.000 |
Why?
|
| Nephrectomy | 1 | 1971 | 155 | 0.000 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 1972 | 147 | 0.000 |
Why?
|
| Osteoporosis | 1 | 1971 | 134 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 1999 | 5164 | 0.000 |
Why?
|
| Leukemia | 1 | 1973 | 374 | 0.000 |
Why?
|
| Heart Failure | 1 | 1983 | 2323 | 0.000 |
Why?
|
| Dyspnea | 1 | 1971 | 159 | 0.000 |
Why?
|
| Leukocytes | 1 | 1971 | 207 | 0.000 |
Why?
|
| Exchange Transfusion, Whole Blood | 1 | 1969 | 11 | 0.000 |
Why?
|
| Hepatitis A | 1 | 1969 | 28 | 0.000 |
Why?
|
| Coma | 1 | 1969 | 56 | 0.000 |
Why?
|
| Extracorporeal Circulation | 1 | 1969 | 47 | 0.000 |
Why?
|
| Renal Artery | 1 | 1969 | 70 | 0.000 |
Why?
|
| Chromosome Disorders | 1 | 1971 | 317 | 0.000 |
Why?
|
| Aorta, Abdominal | 1 | 1969 | 95 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1973 | 1122 | 0.000 |
Why?
|
| Microcephaly | 1 | 1971 | 348 | 0.000 |
Why?
|
| Anus, Imperforate | 1 | 1987 | 19 | 0.000 |
Why?
|
| Intestinal Atresia | 1 | 1987 | 22 | 0.000 |
Why?
|
| Pedigree | 1 | 1971 | 1674 | 0.000 |
Why?
|
| Glomerular Filtration Rate | 1 | 1970 | 568 | 0.000 |
Why?
|
| Hernia, Umbilical | 1 | 1987 | 42 | 0.000 |
Why?
|
| Body Weight | 1 | 1971 | 984 | 0.000 |
Why?
|
| T-Lymphocytes | 1 | 1975 | 1712 | 0.000 |
Why?
|
| Sepsis | 2 | 1974 | 495 | 0.000 |
Why?
|
| Eye Diseases | 2 | 1981 | 108 | 0.000 |
Why?
|
| Neural Conduction | 1 | 1986 | 82 | 0.000 |
Why?
|
| Thyroid Function Tests | 2 | 1974 | 17 | 0.000 |
Why?
|
| Immunoglobulins | 2 | 1977 | 155 | 0.000 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1972 | 877 | 0.000 |
Why?
|
| Candidiasis | 1 | 1965 | 132 | 0.000 |
Why?
|
| Electrocardiography | 2 | 1979 | 975 | 0.000 |
Why?
|
| Spondylolisthesis | 1 | 1983 | 6 | 0.000 |
Why?
|
| Skin Tests | 2 | 1972 | 100 | 0.000 |
Why?
|
| Hydroxycholecalciferols | 1 | 1979 | 6 | 0.000 |
Why?
|
| Ergocalciferols | 1 | 1979 | 5 | 0.000 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1980 | 60 | 0.000 |
Why?
|
| Growth Hormone | 1 | 1980 | 129 | 0.000 |
Why?
|
| Magnesium | 1 | 1979 | 114 | 0.000 |
Why?
|
| Intestinal Absorption | 1 | 1979 | 170 | 0.000 |
Why?
|
| Retinal Degeneration | 1 | 1980 | 91 | 0.000 |
Why?
|
| Angiography | 1 | 1979 | 181 | 0.000 |
Why?
|
| Purpura, Thrombocytopenic | 1 | 1977 | 6 | 0.000 |
Why?
|
| Splenomegaly | 1 | 1977 | 32 | 0.000 |
Why?
|
| Central Nervous System | 1 | 1979 | 274 | 0.000 |
Why?
|
| Leukopenia | 1 | 1977 | 43 | 0.000 |
Why?
|
| Clitoris | 1 | 1976 | 4 | 0.000 |
Why?
|
| Drug Therapy, Combination | 1 | 1979 | 1167 | 0.000 |
Why?
|
| Antihypertensive Agents | 1 | 1979 | 417 | 0.000 |
Why?
|
| Anti-Bacterial Agents | 2 | 1980 | 2568 | 0.000 |
Why?
|
| Breast | 1 | 1976 | 214 | 0.000 |
Why?
|
| Thyrotropin-Releasing Hormone | 1 | 1974 | 8 | 0.000 |
Why?
|
| Thyrotropin | 1 | 1974 | 49 | 0.000 |
Why?
|
| Testis | 1 | 1976 | 389 | 0.000 |
Why?
|
| Iodine Radioisotopes | 1 | 1974 | 65 | 0.000 |
Why?
|
| Lymphangiectasis | 1 | 1974 | 2 | 0.000 |
Why?
|
| Osteolysis | 1 | 1974 | 9 | 0.000 |
Why?
|
| Mesentery | 1 | 1974 | 26 | 0.000 |
Why?
|
| Goiter | 1 | 1974 | 9 | 0.000 |
Why?
|
| Radioimmunoassay | 1 | 1974 | 82 | 0.000 |
Why?
|
| Capillaries | 1 | 1974 | 64 | 0.000 |
Why?
|
| Lymphoma | 1 | 1977 | 328 | 0.000 |
Why?
|
| Femur | 1 | 1974 | 79 | 0.000 |
Why?
|
| Ribs | 1 | 1974 | 52 | 0.000 |
Why?
|
| Thyroid Gland | 1 | 1974 | 99 | 0.000 |
Why?
|
| Diabetes Insipidus | 1 | 1972 | 16 | 0.000 |
Why?
|
| Paralysis | 1 | 1972 | 28 | 0.000 |
Why?
|
| Sciatic Nerve | 1 | 1972 | 57 | 0.000 |
Why?
|
| Friedreich Ataxia | 1 | 1972 | 30 | 0.000 |
Why?
|
| Infusions, Parenteral | 1 | 1972 | 78 | 0.000 |
Why?
|
| Vision Disorders | 1 | 1974 | 193 | 0.000 |
Why?
|
| Lipodystrophy | 1 | 1972 | 37 | 0.000 |
Why?
|
| Endocrine System Diseases | 1 | 1972 | 43 | 0.000 |
Why?
|
| Lymph Nodes | 1 | 1974 | 356 | 0.000 |
Why?
|
| Jaundice | 1 | 1972 | 27 | 0.000 |
Why?
|
| Fever | 1 | 1974 | 309 | 0.000 |
Why?
|
| Immunodiffusion | 1 | 1971 | 9 | 0.000 |
Why?
|
| Immunity, Cellular | 1 | 1972 | 193 | 0.000 |
Why?
|
| Prednisone | 1 | 1971 | 239 | 0.000 |
Why?
|
| Biopsy | 1 | 1974 | 1244 | 0.000 |
Why?
|
| Intestines | 1 | 1974 | 587 | 0.000 |
Why?
|
| Lymphocyte Activation | 1 | 1972 | 632 | 0.000 |
Why?
|
| Cholestasis | 1 | 1972 | 170 | 0.000 |
Why?
|
| Methods | 1 | 1969 | 95 | 0.000 |
Why?
|
| Renal Veins | 1 | 1969 | 31 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 1976 | 1921 | 0.000 |
Why?
|
| Gastrointestinal Diseases | 1 | 1972 | 337 | 0.000 |
Why?
|
| Hypertrophy | 1 | 1969 | 99 | 0.000 |
Why?
|
| Hypogonadism | 1 | 1972 | 296 | 0.000 |
Why?
|
| Aortography | 1 | 1969 | 151 | 0.000 |
Why?
|
| Skin | 1 | 1971 | 537 | 0.000 |
Why?
|
| Insulin Resistance | 1 | 1972 | 687 | 0.000 |
Why?
|
| Insulin | 1 | 1972 | 1140 | 0.000 |
Why?
|
| Phenotype | 1 | 1976 | 4473 | 0.000 |
Why?
|
| Swine | 1 | 1969 | 1185 | 0.000 |
Why?
|
| Electroencephalography | 1 | 1969 | 846 | 0.000 |
Why?
|